GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kancera AB (OSTO:KAN) » Definitions » Cash Payments

Kancera AB (OSTO:KAN) Cash Payments


View and export this data going back to 2011. Start your Free Trial

What is Kancera AB Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.


Kancera AB Business Description

Traded in Other Exchanges
Address
Karolinska Institutet Science Park, Banvaktsvagen 22, Solna, SWE, 171 48
Kancera AB develops drugs that counteract damage in acute and chronic inflammation. The fractalkin blockers KAND567 and KAND145 are developed to effectively counteract hyperinflamation in various disease states and thereby protect vital organs in conjunction with myocardial infarction and severe viral infections. Kancera is planning two phase II clinical trials, in covid-19 and in cardiac patients. The company conducts research and development within the Karolinska Institute Science Park in Stockholm.